Scientists have created a new drug for influenza
2020-02-26
A group of researchers that included staff of TSU, the Institute for Problems of Chemical and Energetic Technologies of the Siberian Branch of the RAS (IPCET SB RAS, Biysk), and the Research Institute of Pharmacology and Regenerative Medicine E.D. Goldberg, has developed a new technology for synthesizing the pharmaceutical substance oseltamivir ethoxysuccinate and received a drug with a double antiviral effect.
- Most pharmaceutical substances are made in China. For Russia, it is important to change this proportion by creating domestic drugs that are not inferior in effectiveness to foreign ones, - says Alexander Vorozhtsov, Vice-Rector of TSU for Science and Innovation, a senior researcher at the IPCET SB RAS. - One of these drugs is the result of the joint work of TSU, two academic institutions, and the research and production center Chemical Technologies. A new technical solution proposed by scientists of the IPCET SB RAS helps to obtain oseltamivir with a high yield of the finished product in relation to the raw materials. There is already a finished form, and the drug has received a patent.Read more: http://en.tsu.ru/news/scientists-have-created-a-new-drug-for-influenza/
